-
Kiefer D. Omega-3 fatty acids and arthritis. Altern Med Alert 2005;8(11):127-131.
-
Greenfield RH. If you're going to drink... Altern Med Alert 2005;8(11):131-132.
-
Get ready to discuss questions about the safety of the Evra contraceptive patch (Ortho-McNeil Pharmaceutical, Raritan, NJ) now that the Food and Drug Administration (FDA) has revised the transdermal contraceptives labeling.
-
Many of your patients may now be using the extended regimen oral contraceptive (OC) Seasonale (Barr Labs, Pomona, NY), where an active pill is taken for 84 days, followed by seven days of placebo pills. But what if there was a pill that would offer continuous dosing with no pill-free intervals?
-
When you scan your next chart, it gives the medical history of a 19-year-old woman who has been sexually active with multiple partners and inconsistently uses condoms. She reports a painful or burning sensation when urinating and increased vaginal discharge. What is your next move?
-
When you review immunization schedules with your adolescent patients this year, will a vaccine for human papillomavirus (HPV) be added to your discussion list? While no vaccine has yet been approved, recent scientific advances signal that such a vaccine soon may become a reality.
-
The 2006 STD Prevention Conference, Beyond The Hidden Epidemic: Evolution or Revolution? will be held May 8-11, 2006, at the Hyatt Regency Jacksonville (FL) Riverfront.
-
The long road toward a woman-controlled form of prevention against HIV infection may have just gotten a little shorter with the recent agreement by two major drug companies to license promising compounds at no charge for microbicide development to a nonprofit group.
-
Intrauterine contraception may see a wider audience in the United States with a major pharmaceutical companys acquisition of the manufacturer of the ParaGard TCu 380A intrauterine device (IUD).
-
Your next patient is a young mother who just gave birth to a healthy infant eight weeks ago. She is breast-feeding her baby and wants to use a safe method of contraception that will not affect her milk supply. What option will she choose?
